Neuroprotective role for the p50 subunit of NF-κB in an experimental model of Huntington's disease

Journal of Molecular Neuroscience

Volumn 15, Issue 1, 2000, Pages 31-44

  Yu, Z ^a   Zhou, D ^b   Cheng, G ^a   Mattson, M P ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Immunology and Rheumatology   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Apoptosis; Calcium; Caspase; Mitochondrial toxin; Nitropropionic acid; Oxidative stress; Striatal neurons; Transcription

Indexed keywords

3 NITROPROPIONIC ACID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPROTECTIVE AGENT; PROTEIN P50; PROTEIN SUBUNIT; SYNAPTOTAGMIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PROTEIN ANALYSIS; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; CONVULSANTS; DISEASE MODELS, ANIMAL; FEMALE; HOMEOSTASIS; HUNTINGTON DISEASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOSTRIATUM; NERVE DEGENERATION; NEURONS; NF-KAPPA B; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONIC ACIDS;

ANIMALIA;

EID: 0034486561     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:15:1:31     Document Type: Article

References (68)

1. Evidence for the involvement TNF and NF-κB in hippocampal synaptic plasticity
2. Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice
3. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase
4. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease
5. NF-κB: Ten years after
6. 2+ accumulation
7. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
8. Aging, energy, and oxidative stress in neurodegenerative diseases
9. Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease
10. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease
11. Trinucleotide repeat length and clinical progression in Huntington's disease
12. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates
13. Altered neuronal and microglial responses to brain injury in mice lacking TNF receptors
14. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults
15. Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum
16. Nuclear factor-κB activity during cerebral reperfusion: Effect of attenuation with N-acetylcysteine treatment
17. Selective activation of NF-κB by nerve growth factor through the neurotrophic receptor p75
18. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and in Alzheimer's disease
19. Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis
20. Global ischemia activates nuclear factor-κB in forebrain neurons of rats
21. IAP family proteins: Suppressors of apoptosis
22. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cere-bellar granule neurons
23. The transcription factor NF-κB mediates increases in calcium currents and decreases in NMDA and AMPA/kainate-induced currents in response to TNF-α in hippocampal neurons
24. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
25. Mitochondrial defect in Huntington's disease caudate nucleus
26. SecretedAPPαcounteracts the pro-apoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostasis
27. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease
28. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knockin mice
29. Huntington's disease collaborative research group
30. Brain synapses contain inducible forms of the transcription factor NF-κB
31. Constitutive NF-κB activity in neurons
32. Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis
33. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons
34. Mitochondrial MnSOD prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction
35. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production
36. 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin
37. Nerve growth factor-dependent activation of NF-κB contributes to survival of sympathetic neurons
38. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration
39. Free radicals, calcium, and the synaptic plasticity-cell death continuum: Emerging roles of the transcription factor NF-κB
40. Evidence for synaptic apoptosis
41. Gene expression of the transcription factor NF-κB in hippocampus: Regulation by synaptic activity
42. Moldy sugarcane poisoning: A case report with a brief review
43. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide
44. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency
45. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease
46. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
47. Nuclear factor-κB in rat brain: Enhanced DNA-binding activity following convulsant-induced seizures
48. Nuclear factor-kappa B contribute to excitotoxin-induced apoptosis in rat striatum
49. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
50. Differential loss of striatal projection neurons in Huntington disease
51. Seizure activity results in a rapid induction of nuclear factor-κB in adult but not juvenile rat limbic structures
52. Nuclear factor-κB in rat brain: Enhanced DNA-binding activity following convulsant-induced seizures
53. Bcl-2 family members in the development and degenerative pathologies of the nervous system
54. Alteration of transcription factor binding activities in the ischemic rat brain
55. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
56. NF-κB is activated and promotes cell death in focal cerebral ischemia
57. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB
58. NF-κB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: A mechanism of resistance in p50 knockout mice
59. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
60. B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching
61. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease
62. Inflammation and glial responses in ischemic brain lesions
63. Inhibition of nuclear factor κB (NFκB) activity induces nerve growth factor-resistant apoptosis in PC12 cells
64. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions
65. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
66. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
67. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
68. Lack of the p50 subunit of NF-κB increases the vulnerability of hippocampal neurons to excitotoxic injury